Calian Group Ltd. · TSX:CGY

Calian — Non-Deal Roadshow (May 2023)

78 slides from Calian's roadshow presentation, May 15, 2023

  1. Slide 1: Investor Presentation

    Investor Presentation Western Canada Roadshow in collaboration with Acumen Capital May 15-16, 2023 1

  2. Slide 2: Caution Regarding Forward Looking Statements

    Caution Regarding Forward Looking Statements Certain information included in this document is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally ac

  3. Slide 3: Table of Contents

    Table of Contents 1 OVERVIEW OF CALIAN 2 EXECUTING ON OUR GROWTH OBJECTIVE 3 DEPLOYING CAPITAL EFFECTIVELY 4 FUNDING GROWTH 5 FOUR-PISTON ENGINE (OPERATING SEGMENTS) 6 Q2-23 RESULTS 7 WHY INVEST IN CALIAN? 3

  4. Slide 4: Overview of Calian

    Overview of Calian 4

  5. Slide 5: Calian – FY22 Snapshot

    Calian – FY22 Snapshot 40 years 4,500 Ottawa $649M CGY History Workforce Head Office Market Cap TSX 30% 26% ITCS Advanced Technologies REVENUE SEGMENTATION Customers Geography Technology $582M 53% 29% 27% 2022 Revenues Commercial International Products 47% 71% 73% Government Canada Services 16% 29%

  6. Slide 6: Key Milestones in 40-Year History

    Key Milestones in 40-Year History 1982 1993 1996 2015 2019 2021 Calian Technology Acquisition Acquisition KevIn Ford Calian Acquisition Ltd. Established Skywave Pricon Staffing becomes announces Dapasoft/iSecurity Initial Public Services President and 4-segment (start of ITCS CEO structure Bought de

  7. Slide 7: Senior Leadership Team

    Senior Leadership Team Kevin Ford Patrick Houston Michele Bedford Sean Hamer Sue Ivay Michael Muldner CEO CFO & Corporate Secretary CCO CTO CHRO CIO Patrick Thera Derek Clark Sacha Gera Don Whitty Advanced Technologies Health IT & Cyber Solutions Learning (Outgoing) Capable and experienced leadershi

  8. Slide 8: Four-Piston Engine

    Four-Piston Engine 30% 29% 26% 16% FY22 ITCS HEALTH ADVANCED TECHNOLOGIES LEARNING REVENUES $173M $167M $150M $92M SUB-SEGMENTS ▪ On-demand Talent & Gov. ▪ Healthcare Professional ▪ Space (53%) ▪ Domestic Defence (75%) Solutions (43%) Services (78%) ▪ Defence (22%) ▪ Global Defence (15%) ▪ IT Soluti

  9. Slide 9: Global Footprint

    Global Footprint Our four-piston engine is gaining a growing global footprint 9

  10. Slide 10: Recent News

    Recent News • May 10/23 – Calian announces the resignation of Sacha Gera, President ITCS (ITCS) • March 9/23 – Calian enters into definitive purchase agreement to acquire US Satellite Communications Provider Hawaii Pacific Teleport (Advanced Tech) • Feb. 24/23 - Calian recognized as an Elite 150 on

  11. Slide 11: Capital Market Profile

    Capital Market Profile CGY $80.00 400,000 $65.17 TSX Close 350,000 $70.00 300,000 7 $60.00 $54.24 Analysts 250,000 52-week Low $50.00 200,000 11.7M 150,000 $71.58 $40.00 # Shares 52-week High 100,000 $30.00 50,000 16,076 $764M $20.00 0 Avg. Daily Volume 2-Apr-18 2-Oct-18 2-Apr-19 2-Oct-19 2-Apr-20 2

  12. Slide 12: Inaugural ESG Report

    Inaugural ESG Report Calian ESG efforts aligned to several United Nations SDGs 12

  13. Slide 13: Executing on our Growth Objective

    Executing on our Growth Objective 13

  14. Slide 14: Four Pillars of Growth

    Four Pillars of Growth 5% 5% 10% Organic Growth + Acquisitive Growth = Target Growth 1 2 3 4 Customer Retention Customer Diversification Innovation Continuous Improvement Through continued delivery Through continued Through continued investment Through continued leverage of excellence, each segment

  15. Slide 15: Growing Revenues, Profitability and Margins

    Growing Revenues, Profitability and Margins Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 582 180 169 40.0% 70 66 160 60 22.0% 518 52 140 127 35.0% 432 50 120 17.0% 343 89 29.1% 30.0% 40 37 305 100 75 27 1

  16. Slide 16: Diversifying Revenue Streams

    Diversifying Revenue Streams Grow Market Share by Generate Higher Margins with De-Risk the Customer Base & Diversifying Internationally Products Generate Higher Margins Geography Offering Customer 20% 19% 25% 22% 18% 20% 25% 27% 29% 33% 32% 31% 47% 49% 53% 80% 81% 75% 78% 82% 80% 75% 73% 71% 67% 68%

  17. Slide 17: Surpassing 10% Annual Revenue Growth Objective

    Surpassing 10% Annual Revenue Growth Objective Acquisitive Revenue Growth Total Revenue Growth Organic Revenue Growth (in %) (in %) (in %) 19% 21% 26% 12% 20% 11% 12% 12% 8% 8% 5% 5% 7% 3% 10% 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 -6% Lapping tough year in Health

  18. Slide 18: Delivering on Guidance

    Delivering on Guidance Revenues Adj. EBITDA1 Adj. Net Profit1 (in millions of $) (in millions of $) (in millions of $) 630-680 70-75 46-50 582 518 66 44 432 52 37 343 37 24 27 19 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 1) This is a non-GAAP measure. Please refer

  19. Slide 19: Starting From a Solid Base

    Starting From a Solid Base Recurring Revenues Revenues Backlog (in millions of $) (in millions of $) 630-680 664 582 518 577 432 261 343 320 Revenues 316 YTD Q2-23 2019 2020 2021 2022 2023E FY23 FY24 Beyond FY24 We have visibility on ~88% of FY23 revenues (at midpoint) 19

  20. Slide 20: Driving Future Revenues

    Driving Future Revenues Backlog New Contract Signings Book-to-Bill Ratio (in billions of $) (in millions of $) 699 1.3 1.33 1.31 1.29 1.2 1.27 1.1 1.23 492 442 447 0.9 0.9 270 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 New contract signings exceed revenues 20

  21. Slide 21: Reaching $1 Billion of Revenues

    Reaching $1 Billion of Revenues Continue to deliver double digit growth Leverage high growth opportunities • Strong FCF • Enhanced cross selling • Increasing margins • Larger M&A deals • Growing into new customers • Focus on high organic growth assets Today Run Rate - End FY25 We have the track reco

  22. Slide 22: Deploying Capital Effectively

    Deploying Capital Effectively 22

  23. Slide 23: Generating Increasing Operating FCF

    Generating Increasing Operating FCF Adj. EBITDA2 Operating Free Cash Flow (OFCF)1&2 OFCF Conversion1&2 (in millions of $) (in millions of $) (in %) 70 66 76% 47 72% 60 66% 52 63% 50 35 50% 40 37 28 30 25 27 17 13 20 10 0 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2) T

  24. Slide 24: Managing Working Capital Requirements

    Managing Working Capital Requirements 700 Net WC as a % Revenue 40.0% (in millions of $, except %) Net Working Capital1 582 35.0% Revenues (in millions of $) 600 (in millions of $) 518 30.0% 582 92 500 90 432 518 80 25.0% 400 432 343 21.2% 20.0% 57 305 343 300 17.4% 305 16.6% 46 15.1% 15.0% 13.8% 20

  25. Slide 25: Deploying Capital to Maximize Shareholder Return

    Deploying Capital to Maximize Shareholder Return 1 Acquisitions 2 Dividends 3 Capex1 (in millions of $) (in millions of $) (in millions of $) 13 66 12 8 7 10 7 49 9 9 6 5 29 21 5 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 1) Capex = Equipment and application software

  26. Slide 26: Describing M&A Strategy

    Describing M&A Strategy • Profitable & growing • Dedicated M&A team • Strategic fit (complementary/scale) • Pipeline: ~10 deals/quarter • Cultural fit • Target closing: ~2-3 deals/year (larger transactions) • Disciplined valuation (do not overpay) • Individual bids & competitive bids Comfortable wit

  27. Slide 27: Completing EBITDA Accretive Acquisitions

    Completing EBITDA Accretive Acquisitions TRANSACTION VALUE DATE ACQUISITION SEGMENT GEOGRAPHY (in millions) TOTAL UPFRONT EARNOUT EARNOOUT PAID Q2-22 Computex ITCS U.S. $38.0 $38.0 $0.0 n/a Q1-22 SimFront Learning Canada $15.0 $9.0 $6.0 YES (on track for 2) Q2-21 Dapasoft ITCS Canada $83.0 $50.0 (ca

  28. Slide 28: Performing Post Acquisition

    Performing Post Acquisition Actions How? • Ability to identify good targets and 9 >$200M 5X complete successful deals Acquisitions Capital deployed Avg. multiple paid upfront (avg. of 2 deals/year) (increasing from <$5M to $80M) (trailing EBITDA) • Deal structure that enables growth • Identification

  29. Slide 29: Acquiring Hawaii Pacific Teleport (HPT)

    Acquiring Hawaii Pacific Teleport (HPT) Financial Highlights Rationale • Acquire the assets for up to C$62M (US$46M) • Blue chip roster of long-term customers (low including C$47M (US$35M) at closing and earn- churn rate) outs of up to C$15M (US$11M) based on the • Trusted relationships with satelli

  30. Slide 30: Maintaining Dividend Payment History

    Maintaining Dividend Payment History Dividends & Dividends/Share Dividend Yield Dividend/OFCF1&2 (in millions of $ & in dollars) (in %) (in %) 14 13 68% 1.80 12 12 1.60 3.7% Target range: 10 1.40 3.2% 51% 25%-30% 10 9 9 1.20 8 1.12 1.12 1.12 1.12 1.12 36% 1.00 2.0% 35% 6 0.80 1.7% 1.8% 27% 4 0.60 0.

  31. Slide 31: Optimizing Capex Spending While Growing

    Optimizing Capex Spending While Growing Equipment & Application Capitalized R&D1 R&D Expensed Software1 (in millions of $) (in millions of $) (in millions of $) 1.8 5.4 7.4 4.7 5.0 7.1 5.4 1.2 1.1 4.6 3.0 2.0 0.4 1.4 0.2 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 1) C

  32. Slide 32: Ramping Up Deals in Equity Investments

    Ramping Up Deals in Equity Investments ECO System Investments Example • Geographical expansion and entry into new • Field Effect Cyber Range – a simulation-based cyber security markets necessitates greater partnership training platform used to grow individual skills, rehearse and eco-system to bring

  33. Slide 33: Funding Growth

    Funding Growth 33

  34. Slide 34: Maintaining a Strong Balance Sheet

    Maintaining a Strong Balance Sheet Total Debt Cash & Cash Equivalents Net Liquidity (in millions of $) (in millions of $) (in millions of $) 79 159 13 5X Avg. multiple paid upfront 115 (trailing EBITDA) 8 43 84 62 24 22 44 17 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022

  35. Slide 35: Ensuring Available Liquidity

    Ensuring Available Liquidity Credit Facility Cash & Cash Equivalents Cash Available (in millions of $) (in millions of $) (in millions of $) 79 40 40 40 40 43 84 24 62 159 22 17 44 115 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 Used Unused Accordian Net Liquidity Acco

  36. Slide 36: Leveraging Capital Structure

    Leveraging Capital Structure Capital Structure Bought Deals (Equity) Operating FCF/share1 (in millions of $) (in $) (in millions of $) $4.16 80 8 5X 69 $3.27 $3.08 Avg. multiple paid upfront (trailing EBITDA) $2.19 305 $1.66 292 Pursue strategic growth 13 initiatives and for general 200 corporate &

  37. Slide 37: Four-Piston Engine (Operating Segments)

    Four-Piston Engine (Operating Segments) 37

  38. Slide 38: ITCS – FY22 Snapshot

    ITCS – FY22 Snapshot ~475 8% / 102% 17% $205M $97M Workforce Organic/Acquisitive Growth EBITDA % New Contract Signings Backlog 26% XaaS and Cyber MDR REVENUE SEGMENTATION 31% Customers Geography Offering IT Solution $173M Provider ~65% ~45% 36% 2022 Revenues Commercial International Products ~35% ~5

  39. Slide 39: ITCS – Financial Performance

    ITCS – Financial Performance Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 173 70.0 50.0%35.0 25.0% 61.1 29.5 45.0% 60.0 30.0 40.0% 20.0% Computex 50.0 35.3% 17.1% 35.0%25.0 acquisition 40.0 30.0%20.0 15.0

  40. Slide 40: ITCS – Business Description

    ITCS – Business Description 43% 31% 26% On-demand Talent and Government Solutions IT Solution Provider XaaS & Cyber MDR PROBLEM SOLVED: PROBLEM SOLVED: PROBLEM SOLVED: • Talent Scarcity • Cloud Transformation • IT & Cyber Scale • Physical Security • Hybrid Work • Geographic Coverage • Government Com

  41. Slide 41: ITCS – Brands That Trust Us

    ITCS – Brands That Trust Us Manufacturing & Retail and Transportation Energy Finance Healthcare Tech and Defence Public Sector Real Estate >1,100 customers to mine for cross-sell and up-sell, at the beginning of this upside 41

  42. Slide 42: ITCS – Business Model

    ITCS – Business Model On-Demand Talent and IT Solution Provider XaaS & Cyber MDR Government Solutions Number • ~50 • ~1,100 • ~300 Size • Public Sector (government) • Mid-Market & Enterprise • Mid-Market Customers • ICT OEMs • Public sector (SLED) • Publc sector (hospitals) Geography • Canada • U.S.

  43. Slide 43: ITCS – Recent Acquisitions

    ITCS – Recent Acquisitions Secure Technologies provides Computex is a leading Dapasoft is a leading provider EMSEC specializes in Radio world-class cyber security Managed IT and Cybersecurity of innovative systems Frequency (RF) emission solutions such as those from solutions provider with a integra

  44. Slide 44: ITCS – Growth Focus & Competitive Advantages

    ITCS – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. Talent and ability to source & scale including government secret cleared 2. N.A. geographic and vertical market focus 3. Breadth/depth of portfolio, sales distribution engine 4. Strategic partners: CRWD, MSFT, CSCO,

  45. Slide 45: Health – FY22 Snapshot

    Health – FY22 Snapshot ~1,550 -14% / 0% 17% $154M $707M Workforce Organic / Acquisitive Growth EBITDA % New Contract Signings Backlog 4% In-store Health Clinics 18% REVENUE SEGMENTATION Pharmaceutical Industry Solutions Customers Geography Offering 78% ~42% ~5% 0% $167M Healthcare Commercial Interna

  46. Slide 46: Health – Financial Performance

    Health – Financial Performance Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 195 55.0 40 50.0% 30.0% 47.8 34.8 163 167 45.0% 35 45.0 41.6 25.0% 40.0% 30 28.3 35.0 32.4 35.0% 23.4 116 25 20.0% 30.0% 18.5 99

  47. Slide 47: Health – Business Description

    Health – Business Description 78% 18% 4% Healthcare Professional Services Pharmaceutical Industry Solutions In-store Health Clinics Manage a network of more than 2,800 Provide clinical trial management services, Design, build and manage all in-store healthcare professionals delivering primary specia

  48. Slide 48: Health – Brands That Trust Us

    Health – Brands That Trust Us The defence industry represents over 50% of Health segment revenues 48

  49. Slide 49: Health – Business Model

    Health – Business Model Healthcare Professional Services Pharmaceutical Industry Solutions In-Store Health Clinics Number >50 >120 products 1 Customers Size Large (public sector) Multi-national large corporations Large national customer (Loblaws) Geography Canada Canada, International Canada Vertica

  50. Slide 50: Health – Recent Acquisitions

    Health – Recent Acquisitions Allphase Clinical Research Inc is a full- Priority One provides specialized Alio Health specializes in the design and service, Contract Research Organization psychological assessment and selection implementation of comprehensive Patient (CRO) providing high quality clini

  51. Slide 51: Health – Growth Focus & Competitive Advantages

    Health – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. Speed and reliability 2. Feature-rich Digital Health Enterprise Management platform (leverage Nexi) 3. Reduction of costs of operation in the pharmaceutical industry (leverage Nexi) 4. Industry-leading KPIs 5. Reim

  52. Slide 52: Advanced Tech. – FY22 Snapshot

    Advanced Tech. – FY22 Snapshot ~925 -10% / 0% 14% $184M $168M Workforce Organic / Acquisitive Growth EBITDA % New Contract Signings Backlog 22% Defense REVENUE SEGMENTATION Customers Geography Offering $150M 53% ~79% ~70% 62% Space Commercial International Products 2022 Revenues ~21% ~30% 38% 25% Go

  53. Slide 53: Advanced Tech. – Financial Performance

    Advanced Tech. – Financial Performance Margin increase due Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) to mix (in millions of $, except margin) (in millions of $) 167 50.0 25.0 30.0% 150 45.0 41.6 43.3 50.0% 21.0 20.9 20.7 153 40.0 20.0 17.7 25.0% 34.0 40.

  54. Slide 54: Advanced Tech. – Business Description

    Advanced Tech. – Business Description 53% 25% 22% Space Terrestrial Defence Global leader in the provision of sophisticated ground-based Provides solutions oriented to a variety of markets. Defence engineering services, solutions and products. solutions to the satellite industry for over 55 years. •

  55. Slide 55: Advanced Tech. – Brands That Trust Us

    Advanced Tech. – Brands That Trust Us Space Terrestrial Defence Customers come to us when failure is not an option 55

  56. Slide 56: Advanced Tech. – Business Model

    Advanced Tech. – Business Model Space Terrestrial Defence Number >100 >500 >10 Size Mixed Mixed Large defence primes Customers Geography Global Global – mostly North American and Europe Mostly North American and Europe Verticals • Communications • GNSS • Military vehicles components and assemblies •

  57. Slide 57: Advanced Tech. – Recent Acquisitions

    Advanced Tech. – Recent Acquisitions Intragrain offers advanced SatService offers innovative Tallysman offers the widest InterTronic Solutions produces tools to monitor grain and engineering solutions and range of precision and high performance antenna fuel storage products for the satellite custom

  58. Slide 58: Advanced Tech. – Growth Focus & Competitive Advantages

    Advanced Tech. – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. Provide antenna solutions to meet or exceed customer requirements at an attractive price 2. Support our customers from pre-sales engineering through to product end-of-life 3. Collaborate with our customers

  59. Slide 59: Learning – FY22 Snapshot

    Learning – FY22 Snapshot ~1,375 7% / 16% 18% $154M $328M Workforce Organic / Acquisitive Growth EBITDA % New Contract Signings Backlog 10% Commercial REVENUE SEGMENTATION 15% Global Customers Geography Offering Defence 75% ~10% ~15% 4% $92M Domestic Commercial International Products 2022 Revenues De

  60. Slide 60: Learning – Financial Performance

    Learning – Financial Performance Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 92 25.0 23.3 50.0% 18.0 16.9 30.0% 45.0% 16.0 75 20.0 17.3 40.0% 14.0 25.0% Simfront 12.4 62 63 35.0% 58 acquisition 12.0 15.0

  61. Slide 61: Learning – Business Description

    Learning – Business Description 75% 15% 10% Domestic Defence Global Defence Commercial Provides simulation-based training for Provides a range of military training for Develops and delivers more engaging, • VCCI – Virtual Command the Canadian Armed Forces. This includes NATO member countries, includ

  62. Slide 62: Learning – Brands That Trust Us

    Learning – Brands That Trust Us Leveraging NATO relationships to gain new opportunities in Europe 62

  63. Slide 63: Learning – Business Model

    Learning – Business Model Domestic Defence Global Defence Commercial Number < 20 <20 >25 Size Large Medium and Large Medium and Large organizations Customers Geography Canada NATO, NATO Nations, Australia, Africa North America Verticals • Defence • Defence • Government & Crown Corporations • Learnin

  64. Slide 64: Learning – Recent Acquisitions

    Learning – Recent Acquisitions Specializes in training, simulation CTS is a Norway based training firm Cadence is a specialized professional technologies and integrating that develops and delivers complex training and consulting firm with platforms focused on strengthening training exercises for the

  65. Slide 65: Learning – Growth Focus & Competitive Advantages

    Learning – Growth Focus & Competitive Advantages Growth Focus Competitive Advantages 1. We have experience and credibility 2. The only military training leader to provide end-to-end synthetic training solutions for high-readiness and collective training 3. Our solution is system-agnostic and interop

  66. Slide 66: Q2-23 Results

    Q2-23 Results 66

  67. Slide 67: Q2-23 Consolidated Results

    Q2-23 Consolidated Results $147M $1.2B 6% 13% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 169 60 40.0% 150 161 52 20.0 19.1 142 148 5

  68. Slide 68: Q2-23 ITCS

    Q2-23 ITCS $61M $110M -4% 57% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 30 65.0% 14.0 35.0% 69 12.4 25.1 60.0% 25 12.0 55.0% 30.0%

  69. Slide 69: Q2-23 Health

    Q2-23 Health $25M $681M -4% -% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 10.0 40.0% 35.0% 14.0 9.0 45 44 8.0 30.0% 40 12.0 11.3 8.0

  70. Slide 70: Q2-23 Advanced Technologies

    Q2-23 Advanced Technologies $48M $157M 18% -% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 47 13.7 45.0% 7.0 14 11.9 6.0 5.7 27.0% 40

  71. Slide 71: Q2-23 Learning

    Q2-23 Learning $13M $299M 16% -% Gross New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $) (in millions of $, except margin) 29 6.0 40.0% 26 9.0 5.4 5.4 25 8.2 32.0% 8.0 5.0 22 22 6

  72. Slide 72: Q2-23 – Cash Flow

    Q2-23 – Cash Flow Operating Free Cash Flow (OCFC)1&2&3 Working Capital Adj. EBITDA2 (in millions of $, except margin) (in millions of $) (in millions of $) 14.1 120% 14.0 13.1 +$6M 19.1 12.0 12.1 100% 16.8 16.8 10.2 10.7 12.4 16.1 85% 14.3 10.0 80% 8.0 78% 74% 8.0 64% 4.1 63% 60% 6.0 40% 4.0 Q2-22 Q

  73. Slide 73: Q2-23 – Capital Deployment

    Q2-23 – Capital Deployment Acquisitions Dividends Capex1 (in millions of $) (in millions of $) (in millions of $) 48 3 3 3 3 +$3M 3 2 2 2 2 1 4 3 3 6 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 1) Capex = Equipment and application software + Capitalized

  74. Slide 74: Q2-23 Balance Sheet

    Q2-23- Balance Sheet Total Debt Cash & Cash Equivalents Net Liquidity (in millions of $) (in millions of $) (in millions of $) 25 130 59 58 124 115 126 114 51 43 46 8 8 8 0 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 Q2-22 Q3-22 Q4-22 Q1-23 Q2-23 1) Net Liquidity= Unused portion of c

  75. Slide 75: FY23 – Guidance Reiterated

    FY23 – Guidance Reiterated Revenues Adj. EBITDA1 Adj. Net Profit1 (in millions of $) (in millions of $) (in millions of $) 630-680 70-75 46-50 582 518 66 44 432 52 37 343 37 24 27 19 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 1) This is a non-GAAP measure. Please r

  76. Slide 76: Why Invest in Calian?

    Why Invest in Calian? 76

  77. Slide 77: Investment Value Proposition

    Investment Value Proposition 1 REVENUE DIVERSIFICATION 6 HIGH FCF CONVERSION RATE 2 STRONG BALANCE SHEET 7 SOLID BACKLOG 3 SUCCESSFUL M&A STRATEGY 8 FOCUS ON ORGANIC GROWTH 4 EXPANDING MARGINS 9 GROWING EQUITY INVESTMENTS 5 POSTIVE TRENDS IN END MARKETS 10 10 AMPLE DRY POWDER TO GROW Established Man

  78. Slide 78: Thank you

    See CALIAN . Thank you ir@calian.com

Calian Group — Non-Deal Roadshow (May 2023) on 6ix